Ban on brand-name drug makers paying to delay cheaper copies
H.R. 10887 — Protecting Consumer Access to Generic Drugs Act of 2026 · Filed by Seth Magaziner (D-RI) · Introduced Oct 22, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
The bill makes it illegal for brand-name drug makers to pay copy makers to wait. They must tell the FTC and DOJ about all deals. The FTC can fine companies up to three times the payment.
Who it affects
Patients get cheaper copy drugs faster because they reach the market sooner. Copy drug makers must follow new rules about deals.
One thing to notice
The bill has a six-year time limit for enforcement. Some old pay-for-delay deals might escape punishment.
From the analysis of the bill text, linked under Primary records below.
Where it stands
- Oct 22, 2026 — Introduced · Congress.gov: “Introduced in House”
- Oct 22, 2026 — Referred to House Committee on the Judiciary and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Words to know
- pay-for-delay — When a brand-name drug maker pays a copy maker to wait before selling.
- copy — A drug that works the same as the original but costs less.
- FTC — The Federal Trade Commission, a federal agency that stops unfair business practices.
- deal — An agreement two companies make to end a legal fight.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (17,917 characters) on Oct 23, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,417 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-24.
“Ban on brand-name drug makers paying to delay cheaper copies” QuorumCivic. https://share.quorumcivic.app/bill/119/hr10887/simple Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.